A detailed history of Boothbay Fund Management, LLC transactions in Biote Corp. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 23,889 shares of BTMD stock, worth $151,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,889
Holding current value
$151,695
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.33 - $8.36 $127,328 - $199,712
23,889 New
23,889 $133,000
Q1 2023

May 15, 2023

SELL
$3.14 - $6.19 $182,308 - $359,391
-58,060 Reduced 77.41%
16,940 $104,000
Q3 2022

Nov 14, 2022

BUY
$3.48 - $4.98 $261,000 - $373,500
75,000 New
75,000 $321,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $48.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.